NCT00289354View on ClinicalTrials.gov

Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM

NACompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

November 30, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Chromium Picolinate (600 mcg Cr) + biotin (2 mg)

All Listed Sponsors
lead

Nutrition 21, Inc.

INDUSTRY

NCT00289354 - Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM | Biotech Hunter | Biotech Hunter